Scienture Holdings (SCNX) Cash & Equivalents (2013 - 2026)

Scienture Holdings has disclosed Cash & Equivalents across 14 years of filings, most recently posting $3.5 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $3.5 million, up 72.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 72.85% YoY), and the FY2025 annual result was $6.7 million, up 2062.32% from the prior year.
• Cash & Equivalents came in at $3.5 million for Q1 2026 at Scienture Holdings, down from $6.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $7.7 million in Q2 2024 to a low of $15391.0 in Q2 2025.
• The 5-year median for Cash & Equivalents is $1.0 million (2022), against an average of $2.1 million.
• Peak annual rise in Cash & Equivalents reached 2062.32% in 2025, while the deepest fall reached 99.8% in 2025.
• Scienture Holdings' Cash & Equivalents stood at $1.1 million in 2022, then plunged by 86.13% to $151907.0 in 2023, then jumped by 102.82% to $308096.0 in 2024, then surged by 2062.32% to $6.7 million in 2025, then sank by 46.82% to $3.5 million in 2026.
• The last three Cash & Equivalents figures came in at $3.5 million (Q1 2026), $6.7 million (Q4 2025), and $15391.0 (Q2 2025), per Business Quant data.